CATO RESEARCH AND JSW RESEARCH SIGN STRATEGIC CRO COLLABORATION AGREEMENT

Cato Research Ltd., a global contract research organization (CRO) providing a full-range of drug development services and regulatory expertise for clients in the pharmaceutical, biotechnology, and medical device industries, and JSW-Research Forschungslabor GmbH, an Austrian CRO specializing in research and development of novel therapeutics for central nervous system (CNS) disorders, announced today a strategic business development collaboration focused on expansion of the companies' operations throughout the European Union and Eastern Europe. Separately, Cato BioVentures, the venture capital affiliate of Cato Research, purchased an undisclosed equity interest in JSW Research.

Verivox.de (http://www.verivox.de/news/ArticleDetails.asp?aid=25853&pm=1)